The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) vs platinum-based doublet as first-line treatment for metastatic or recurrent PD-L1-positive non-small-cell lung cancer: The phase 3 JAVELIN Lung 100 trial.
 
Martin Reck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Pfizer; Roche
 
Hyatt P. DeGreen
Employment - Lannett
 
Andrea L. Rose
No Relationships to Disclose
 
Nick Pavlakis
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Sanofi; Specialised Therapeutics
 
Sofie Maria Derjcke
No Relationships to Disclose
 
Jasna Radic
Honoraria - Amgen; Pfizer; Roche
Consulting or Advisory Role - Amgen
 
Nina Jeppesen
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Roche
 
Michael Thomas
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Gyorgy Losonczy
No Relationships to Disclose
 
Ewa Kalinka-Warzocha
Leadership - Center for Cancer and Blood Disorders
Honoraria - Angimmune; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Angimmune; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Lydia Mary Dreosti
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - Amgen; Janssen; Novartis
Travel, Accommodations, Expenses - Janssen; Merck; Roche; Sanofi
 
Mustafa Ozguroglu
No Relationships to Disclose
 
Pieter E. Postmus
Employment - Clatterbridge Cancer Centre
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Roche
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Christoph Helwig
Employment - Merck KGaA
Patents, Royalties, Other Intellectual Property - Merck KGaA
 
Vikram Chand
Employment - Boehringer Ingelheim; EMD Serono
Leadership - Boehringer Ingelheim; EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim; EMD Serono
Travel, Accommodations, Expenses - Boehringer Ingelheim; EMD Serono
Other Relationship - Boehringer Ingelheim; EMD Serono
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
Virginie Westeel
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Pierre Fabre
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Research Funding - AstraZeneca; Merck Serono (Inst); Roche/Genentech (Inst); Transgenomic (Inst)
Expert Testimony - Teva
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Pfizer; Pierre Fabre; Roche